fda warning letter glp-1 solution september 2025 issues 30 letters to online compounders FDA Warns 30 Telehealth Companies

GLP-1 drugs like Ozempic and Wegovy are groundbreaking treatments for type 2 diabetes and obesity

To offer a gentle boost you can use daily

Notably, this followed the 2021 Food and Drug Administration (FDA) approval for the brand formulation of semaglutide, Wegovy, which became the second GLP-1 RA to gain approval for weight loss

Both vaccines require two doses, spaced a few weeks apart, so make sure the second dose is the same type as the first

For example, the company is working on an oral GLP-1/GIP candidate (a new drug that could rival Oral Semaglutide)

Patients should be informed to take valproic acid every day as prescribed